Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
163.12
-0.76 (-0.46%)
At close: Jun 8, 2026, 4:00 PM EDT
164.77
+1.65 (1.01%)
After-hours: Jun 8, 2026, 5:49 PM EDT

Neurocrine Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
16,40214,19713,56813,00511,5268,083
Market Cap Growth
37.47%4.64%4.33%12.83%42.60%-9.81%
Enterprise Value
15,54913,13212,94712,23110,6307,812
Last Close Price
163.12141.83136.50131.76119.4485.17
PE Ratio
25.0930.3741.4953.3476.5692.58
Forward PE
14.5915.8718.1521.3422.5324.55
PEG Ratio
0.340.750.310.650.370.37
PS Ratio
5.294.965.766.897.747.13
PB Ratio
4.824.365.245.836.755.88
P/TBV Ratio
4.914.475.475.966.926.07
P/FCF Ratio
19.7318.9624.3535.9635.7034.67
P/OCF Ratio
18.9918.1422.7933.3533.9631.51
EV/Sales Ratio
5.014.595.506.487.146.89
EV/EBITDA Ratio
18.7720.2321.6744.9440.1768.89
EV/EBIT Ratio
19.4721.2122.6948.7542.6976.21
EV/FCF Ratio
18.7017.5423.2433.8332.9233.51
Debt / Equity Ratio
0.120.130.180.120.050.32
Debt / EBITDA Ratio
0.500.640.761.570.993.88
Debt / FCF Ratio
0.490.560.821.190.811.89
Net Debt / Equity Ratio
-0.27-0.33-0.24-0.27-0.42-0.20
Net Debt / EBITDA Ratio
-1.11-1.64-1.04-2.22-2.74-2.39
Net Debt / FCF Ratio
-1.09-1.42-1.11-1.67-2.25-1.16
Asset Turnover
0.650.690.680.670.670.60
Inventory Turnover
0.850.820.711.080.710.49
Quick Ratio
2.512.923.062.252.493.65
Current Ratio
2.933.393.402.452.703.96
Return on Equity (ROE)
20.08%16.38%14.16%12.68%10.03%7.17%
Return on Assets (ROA)
11.80%10.06%11.50%6.71%8.10%4.76%
Return on Invested Capital (ROIC)
21.26%18.04%19.88%12.77%16.05%9.53%
Return on Capital Employed (ROCE)
19.82%17.44%19.65%11.33%13.62%6.07%
Earnings Yield
4.08%3.29%2.41%1.87%1.31%1.08%
FCF Yield
5.07%5.27%4.11%2.78%2.80%2.88%
Buyback Yield / Dilution
0.68%1.16%-2.67%-2.12%-1.02%-0.10%
Total Shareholder Return
0.68%1.16%-2.67%-2.12%-1.02%-0.10%
SEC Filings: 10-K · 10-Q